Stability of extemporaneously prepared 0.5-percent caspofungin eye drops: A potential cost-savings exercise

12Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

While the successful use of topical caspofungin for patients has been reported, topical caspofungin is not commercially available and its stability is unknown, limiting its usefulness in treating fungal keratitis. Caspofungin (0.5%) eye drops were aseptically prepared, and the concentrations were measured using a validated high-performance liquid chromatography (HPLC) analysis. The preparations remained stable for 28 days under refrigerated condition but not at 25.0°C. Our study supports the cost-saving use of caspofungin eye drops in the clinical setting. Copyright © 2012, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Neoh, C. F., Jacob, J., Leung, L., Li, J., Stathopoulos, A., Stewart, K., & Kong, D. C. M. (2012). Stability of extemporaneously prepared 0.5-percent caspofungin eye drops: A potential cost-savings exercise. Antimicrobial Agents and Chemotherapy, 56(6), 3435–3437. https://doi.org/10.1128/AAC.00060-12

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free